ARQT SG&A Expense Growth
Arcutis Biotherapeutics Inc · SG&A Expense Growth
ARQT SG&A Expense Growth
Latest reported19.69%period ending
ARQT FY SG&A Growth (YoY) (0.00% → 19.69%)
Latest values, visible window
High-resolution chart · PNG
ARQT sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 19.6878% | |
| 23.898% | |
| 51.6041% | |
| 100.2985% | |
| 191.9787% | |
| 225.5183% | |
| 257.3816% | |
| 158.2734% | |
| 0% |